The FDA reviewed T2Candida through its de novo classification process for certain novel low-to-moderate-risk medical devices. In a clinical study, T2Candida demonstrated a sensitivity of 91.1% and ...
Thrush is one of the most common infections in the world. It's caused by the fungi Candida – specifically, the yeast Candida ...
Nosocomial candidaemia is associated with high mortality rates in critically ill paediatric patients; thus, the early detection and identification of the infectious agent is crucial for successful ...
Diagnosing a dangerous infection by a fungal yeast that often devastates hospital patients is now faster and more efficient. The new blood test has the potential to improve patient outcomes, as the ...
WOBURN, Mass., June 3 /PRNewswire/ -- AdvanDx today announced the FDA 510(k) submission of Yeast Traffic Light PNA FISH(TM) for detection of Candida yeast species from positive blood cultures. Yeast ...
An antifungal drug demonstrated early signs of effectiveness in human testing, San Diego biotech Amplyx Pharmaceuticals said Monday. Privately held Amplyx also said it has acquired rights to another ...
What Are the Symptoms of Invasive Candidiasis? People who have other medical conditions are often at risk of getting invasive candidiasis. It can be difficult to tell which symptoms are caused by ...
A study by a team of clinicians and scientists from Manchester University NHS Foundation Trust and The University of Manchester, published in the latest issue of the Journal of Antimicrobial ...
A new, rapid test for Candida infections of the bloodstream may cut mortality from 40% to 11%, according to a report published in the April 24 issue of Science Translational Medicine. Lori A. Neely, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback